Patient with metastatic breast cancer, HER$2$ positive, was recommended Herceptin.

Patient lost to follow$-$up without returning for Herceptin infusion, no details stated

in record.

a$.00$

b$.01$

c$.85$

d$.86$ standard for oncology registry